Hoxworth Blood Center Welcomes New Chief Medical Officer
Hoxworth Blood Center is welcoming a new chief medical officer. David Oh, MD, assumes that role on Oct. 30, 2017, taking over for the recently retired Patricia Carey, MD.
Oh brings more than 15 years of experience in blood banking medical oversight to Hoxworth. For the past four years, Oh served as medical director at Stanford Blood Center in California. Prior to that, he served for nine years as the medical director of the San Diego Blood Bank and for two years as the associate medical director of the American Red Cross Blood Services in the Western Lake Erie Region.
"Dr. Ohs expertise will help us support and strengthen the services we provide to patients and donors in the Tri-State, says Ronald Sacher, MD, Hoxworth Blood Center director, and professor in the Department of Internal Medicine at the UC College of Medicine. "He brings many attributes to the senior leadership of Hoxworth and will play a key role in our clinical and strategic efforts going forward.
Oh, a Wisconsin native, graduated from the University of Wisconsin-Madison and received his medical degree from the University of Wisconsin School of Medicine. Following a five-year residency in anatomic and clinical pathology at the Cleveland Clinic, he completed a blood banking/transfusion medicine fellowship at the BloodCenter of Wisconsin/Medical College of Wisconsin.
Oh will have a faculty appointment as an associate professor in the Department of Pathology and Laboratory Medicine at the UC College of Medicine.
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.